Yale Cancer Center

This morning, Dr. Zachary Yochum presented research on cell-of-origin analysis for #renalcellcarcinoma. For this research, Dr. Yochum was awarded a #ConquerCancer Merit Award which recognizes outstanding research in abstracts at #ASCOGU26.
meetings.asco.org/meetings/2026-…
@braunmdphd.bsky.social

SurgOnc Today®: SSO Education Series: Reflecting on the Newly Updated PSM Consortium Guidelines Leaders in PSM and co-creators of the Yale consensus guidelines meet to discuss key aspects of the recently updated consortium recommendations.

Dr. Kiran Turaga joined the @socsurgonc.bsky.social podcast #SurgOncToday to discuss the newly endorsed guidelines from the Yale Peritoneal Surface Malignancy Consortium. #PSM
surgonctoday.libsyn.com/sso-educatio...

At 11:30am PST, Dr. Daniel Petrylak presents results of a QI initiative on 1st line combination therapy + biomarker testing in #urothelialcarcinoma in community settings. #ASCOGU26
meetings.asco.org/meetings/202...

Using Machine Learning to Develop Personalized Vaccines for Cancer A new tool combines multiple types of data to better support the development of vaccines that target patient-specific pathology.

Led by @virusesimmunity.bsky.social and @krishnaswamylab.bsky.social, a team of Yale researchers developed a new tool #Immunostruct that combines multiple types of data to better support the development of personalized vaccines, including vaccines for #cancer.
medicine.yale.edu/news-article...

In the Trials in Progress Poster Session A starting at 11:30am PST #ASCOGU26, Dr. Daniel Petrylak shares an update on the LuxAR-02 Phase II study for PSMA-positive metastatic castration resistant #prostatecancer. meetings.asco.org/meetings/202...

It's day one of #ASCOGU26, and starting at 11:30am PST,
@mleapman.bsky.social will present two posters during Poster Session A on #prostatecancer. meetings.asco.org/meetings/202...
@carygross.bsky.social

Congratulations to John Kunstman, MD, MHS, recipient of the
@yalecancer.bsky.social Clinical Excellence Award by Dr. Kiran Tiraga. Dr. Kunstman is a surgical oncologist specializing in the care of patients with cancers or benign diseases of the pancreas, liver, bile ducts, stomach, and intestines.

Yale scientists led by Dr. Sidi Chen have engineered natural killer cells that eliminate solid tumors in mouse models. Dr. Chen: “We really believe this type of therapy has immense potential in patients.”
news.yale.edu/2026/02/25/c...
@nature.com

PIK3CA Mutations in Early-Onset Appendiceal Adenocarcinoma | JCO Precision Oncology PURPOSEApproximately one in three patients with appendiceal cancer (AC) is diagnosed before age 50 years. Early-onset appendiceal cancer (EOAC) exhibits distinct clinicopathologic and demographic feat...

New research led by @princygupta.bsky.social + Dr. Kiran Turaga on early-onset appendiceal cancer shows ⬆️ rates of PIK3CA mutations which are associated with worse survival. Findings point to new opportunities for molecular risk stratification and targeted therapy.
ascopubs.org/doi/10.1200/...

Members of our #thoraciconcology team attended the IASLC 2026 Targeted Therapies of Lung Cancer Meeting #TTLC26 last week, a conference sharing the latest breakthroughs in clinical research and targeted therapies for #lungcancer.

Congratulations to Karen Hammond, DNP, APRN, ACNP (BC), AOCNP, who was presented with the Ruth McCorkle Oncology Advanced Practice Provider (APP) Award by Dr. Toby Bressler at our recent Annual Awards Program!

February is #NationalCancerPreventionMonth, and tonight on #YaleCancerAnswers, Dr. Michaela Dinan @yalesph.bsky.social joins to talk about the shifting landscape of cancer prevention screening and risk stratification.
🎧Listen live #WNPR
🔁Download #ApplePodcasts
💻Listen later #YouTube

Tumors Protect Themselves from Immune Attack by Talking to the Brain Researchers found that tumor-brain communication activated signaling that blocked immune activity against the cancer.

Yale researchers find tumors can hijack nerves to communicate with the brain + block immune system response. But “there’s lots of potential to use this to fight tumor growth,” says Dr. Rui Chang @yaleneuro.bsky.social.
medicine.yale.edu/cancer/news-...
@oncoalert.bsky.social

Join the #NCI Childhood Cancer Data Initiative #CCDI for a webinar today at 1pm featuring Dr. Prasanna Ananth of #YalePediatrics sharing how patient-report outcomes (PROs) data can drive change across child, adolescent, and young adult cancer care.
RSVP ➡️ events.cancer.gov/ccdi/webinar...

Today at 12pm, Dr. Anne Chiang presents our #GrandRounds on the topic of "Small Cell #LungCancer: Updates, Progress, and Promise of 'Targeted Therapy.'" Please join us in Smilow Auditorium or online via Zoom: bit.ly/46wi4dp. #lcsm

Tonight at 7:30pm on #YaleCancerAnswers, Dr. Henry Park joins the program to talk about the proliferation of cancer misinformation and scams on social media.
🔹 Listen live #wnpr
🔹 Download #ApplePodcasts
🔹 Listen later #YouTube

Congratulations to #YaleCancerAnswers, our award-winning radio show and #podcast, which has added another honor to its portfolio. #FeedspotPodcast has named it as one of the top #Connecticut Medical Podcasts!
Learn more: medicine.yale.edu/cancer/news/...

Creating New Tools for Radioligand Therapy Sheryl Roberts, PhD, has joined the faculty in the Department of Radiology and Biomedical Imaging as an assistant professor. Her new lab will develop chemical

Meet Sheryl Roberts, PhD, who recently joined #YaleRadiology. Her lab develops chemical tools to identify disease locations for #PET imaging and theranostics to support #cancer treatment.
medicine.yale.edu/news-article...

Thank you to Dr. Vijay Sankaran @bloodgenes.bsky.social
@bostonchildrens.bsky.social for presenting our annual Richard Frisbee, III Grand Rounds Lecture on how human genetic variation can teach us about #hematopoiesis.
@yale-hematology.bsky.social

Eye Cancer Genes Predetermine Its Spread to the Liver A new study has identified biomarkers on a rare, aggressive eye cancer that predict its future spread to the liver.

A new study by Dr. Mathieu Bakhoum has identified biological markers for a rare, aggressive #eyecancer that predict the likelihood of secondary tumors forming in the liver. #uvealmelanoma
medicine.yale.edu/news-article...

Expert recommendations for the conduct and appraisal of qualitative research in haematology Haematological disorders constitute a public health crisis in more than 160 countries worldwide. Despite millions afflicted, people with haematological diagnoses remain underserved and understudied. T...

In this review article, findings from Yale experts highlight the value of qualitative research for improving health outcomes for people with hematological disorders + their communities and present an expert-informed roadmap.
thelancet.com/journals/lan...
@thelancethaem.bsky.social

The @yalecancer.bsky.social Population Science Research Award, presented by Melinda Irwin, PhD, MPH, was awarded to Xuehong Zhang, PhD, for his study: "Proteomic signatures of sweetened beverages are associated with higher risk of adverse liver outcomes," published in #NatureFood.

Consensus Molecular Subtypes Inform HIPEC Agent Selection in Colorectal Cancer Peritoneal Metastases - Annals of Surgical Oncology Background Although hyperthermic intraperitoneal chemotherapy (HIPEC) added to cytoreductive surgery shows promise for colorectal cancer with peritoneal metastases (CRC-PM), effectiveness remains vari...

New research from Dr. Kiran Turaga shows how in #colorectalcancer with peritoneal metastases, CMS4 tumors have unique drug sensitivities, highlighting the need for subtype-guided personalized #HIPEC strategies.
link.springer.com/article/10.1...
@annsurgoncology.bsky.social @jsheltzer.bsky.social

Yale Study Identifies a New Class of Drug Targets for Aggressive Leukemia Hyperactive signaling pathways of some aggressive blood cancer cells can be tamped down by a previously unrecognized protein complex, ensuring the cancer’s

A new Yale-led study from @muschenlab.bsky.social
uncovers how some aggressive #leukemia cells rely on CD25 as a molecular brake. Removing it sends cells into overdrive and they die, revealing a new angle for cancer drug development.
medicine.yale.edu/cancer/news-...
@oncoalert.bsky.social

Please join us at 12pm as Dr. Vijay Sankaran
@bloodgenes.bsky.social @bostonchildrens.bsky.social
presents #GrandRounds on the topic of "How Human Genetic Variation Can Teach Us About Hematopoiesis."
Join us in Smilow Auditorium or online via Zoom. bit.ly/4bHlJbB

Research from Dr. Prasanna Ananth and her lab describes how a novel parent-reported questionnaire: “Pediatric Cancer Care Experience” (PACE) evaluates the quality + experiences of care in children with advanced #cancer.
sciencedirect.com/science/arti...

New research led by Dr. Etienne Caron shows how #melanoma cells release pigment-containing particles that act as decoys, interfering with immune T cells’ ability to kill #cancer. Targeting this pathway may boost #immunotherapy success.
science.org/doi/10.1126/...

Tonight at 7:30pm on #YaleCancerAnswers, Dr. Sarah Hull joins to discuss the field of cardio-oncology, including caring for patients with cancer with underlying cardiac problems and those who develop cardiac problems from cancer.
🎧Listen live #WNPR
🔁Download via #ApplePodcasts
💻Listen later #YouTube

Don't miss our annual Post-ASH Review, hosted by
Dr. Natalia Neparidze, Friday, March 13. Our @yale-hematology.bsky.social experts will be sharing highlights and key takeaways from the American Society of Hematology’s Annual Meeting.
RSVP: bit.ly/3ZOATo6

Drs. Diane Krause and Stephanie Halene (not pictured) were presented with the @yalecancer.bsky.social Basic Science Research Award for their research identifying new & promising targets for future treatments in patients with acute megakaryoblastic leukemia. #AMKL ashpublications.org/blood/articl...